Drug Target Review has launched an updated website to improve access to content across early-stage drug discovery, alongside a new membership model that provides full access to premium analysis, reports and expert commentary.
Following several months of development, Drug Target Review has deployed an updated website to improve how scientists and industry professionals working in early-stage drug discovery find and use content.
The site has been redeveloped to improve how readers identify relevant information, assess its value and apply it across drug target identification, validation and early development. As the volume of published research continues to grow, efficient access to reliable, well-structured content is essential.
The site has been reworked across navigation, search and content organisation. Key improvements include:
- Improved navigation and structure across topic areas
- More effective search and discoverability of relevant content
- Clearer organisation of research, analysis, news, reports and commentary
- Improved performance across mobile and desktop devices.
Alongside the website update, Drug Target Review is introducing a new membership model for professionals who need access to detailed, reliable information beyond surface-level coverage. Membership provides full, unrestricted access to premium material, including in-depth analysis, research and expert commentary, available to members only.
For researchers and industry professionals, this means access to content that supports day-to-day work, from tracking developments in targets and technologies to evaluating approaches across early-stage pipelines.
Membership includes:
- Detailed coverage of emerging targets, technologies and approaches
- Analysis to support decision making across early-stage pipelines
- A weekly newsletter covering key developments across drug discovery
- Access to webinars and virtual events featuring industry experts
- In-depth reports exploring scientific advances and sector trends
- A ‘My Library’ feature to save and organise content for future reference.
The updated website is now live, with full access to premium content available to members. For those working in fast-moving and data-intensive areas of drug discovery, membership offers the depth of coverage needed to stay informed and make confident decisions.
Access deeper intelligence for drug discovery by becoming a member today, with unrestricted entry to the platform and full ‘My Account’ functionality. Save and organise content in your personalised ‘My Library’, while keeping up to date with expert newsletters, exclusive events, webinars, in-depth market reports and the latest research.
No comments yet